Table 3. Inclusion criteria for TARGIT-US trial.
| Age ≥45 years |
| Invasive breast cancers other than lobular |
| T1 and T2 (<3.5 cm), N0-1, M0 |
| ECOG performance status of 0–3 |
| Informed consent |
ECOG = Eastern Cooperative Oncology Group
| Age ≥45 years |
| Invasive breast cancers other than lobular |
| T1 and T2 (<3.5 cm), N0-1, M0 |
| ECOG performance status of 0–3 |
| Informed consent |
ECOG = Eastern Cooperative Oncology Group